Feed/Investors/Mirae Asset Capital Life Science

Mirae Asset Capital Life Science

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-10-28

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$350M

across 1 round

LATEST ROUND

Funding round · $350M · 2026-10-28

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Dren Bio A privately held, clinical-stage biotechnology company developing first-in-class antibody therapeutics for cancer, autoimmune, and other serious diseases	Funding round Verified against 2 of 3 sources	$350M	2026-10-28	[ PART ]